Tehran, Jan 09: Iran is the first country that uses plasma to cure ocular diseases, a health official said on Saturday, adding that the special plasma surgery is being used to treat nearly 15 eye diseases.
Plasma Assistance Non-Invasive Surgery (PANIS) inventor Farhad Nejat said that Iran is the first country that applies the method in the world to treat eye diseases, and noted that 14-15 eye diseases that needed operating room and anesthesia are now treated by the PANIS method.
“The International Eye Surgery Academy has approved the PANIS method,” he said.
The inventor made it clear that the method’s animal trial had taken around one and half years and its human trial began two years ago.
Nejat went on to say that many European countries like Italy, Germany, Spain, Ukraine, and some of the regional countries like Turkey are exchanging their experiences with Iran.
“Over the past 20 years, plasma therapy has been applied for treating cancer, dentistry, dermatology, scar, and in the past four years has successfully been applied on ocular surface disorders, which compromise the integrity of the cornea surface and conjunctiva,” he stated.
“PANIS generator is made in Italy, but the method is absolutely indigenized,” Nejat highlighted.
“Safety, easy use, low price, the fast-paced wound healing process, and promoting ocular surface regeneration in different pathological conditions are the most noteworthy features of the method,” the ophthalmologist stressed.
The ceremony of the PANIS method introduction was held in Tehran on 8th January 2021. Specialists of an Iranian knowledge-based company introduced the discovery of a new method to treat eye diseases without the need for operating-room, pain, and anesthesia.
In a relevant event in late December, Iran’s Health Minister Saeed Namaki said that the country has a century of experience and know-how in the production of vaccines, and announced that the human trial of the COVID-19 vaccine has started with the first injection of the domestic vaccine.
“We have been producing vaccines in the country for a hundred years. Pasteur Institute of Iran was set up in 1920 and Razi Vaccine and Serum Research Institute was founded in 1924,” Namaki said on December 29 on the sidelines of the unveiling ceremony of the vaccine and the first phase of the clinical trial of Iranian-made COVID-19 vaccine on 56 volunteers.
“We were the first producer of vaccines in Asia and we have sent vaccines to many countries in the world,” he added.
“Due to our record in vaccine production, we are trying to offer new vaccines with the help of the Science and Technology Vice-Presidency, knowledge-based companies, the Pasteur Institute of Iran, the Razi Vaccine and Serum Research Institute and the private sector,” the minister noted.
“We have developed various platforms for coronavirus, including the vaccine, the first human phase of which was performed today,” Namaki said, and added, “Another platform is also underway at Razi Institute, and its animal tests are underway and will soon receive a human testing license.”
“We hope that we will soon see the start of the second human trial phase of this national vaccine and then the third phase to be followed by its mass production,” he continued.
The Headquarters for Executing the Order of Imam (Khomeini) announced the start of the first phase of the clinical trial of Iranian-made COVID-19 vaccine on 56 volunteers in Tehran on Tuesday.
The COVID-19 vaccine produced by EIKO has been licensed by the Iranian Ministry of Health and Medical Education.
In J&K, over six lakh children anaemic, reveals NITI Aayog
(Asian News Hub) – In Jammu and Kashmir, over six lakh children have anaemia while more than two lakh children are stunted, reveals NITI Aayog State Nutrition Profile 2021.
According to the figures of NITI Aayog study titled State Nutrition Profile of Jammu and Kashmir accessed by the news agency—Kashmir News Observer (KNO), “Over 625,519 children are anaemic and 251,393 are stunted in J&K. The findings are based on data from the National Family Health Survey (NFHS) 3 (2005-2006), 4 (2015-2016), and 5 (2019-2020).”
The anaemic data in the report reveals that in J&K 20 out of 20 districts shows public health concern.
As per the data, Anantnag is the highest-burden district with 69,576 numbers of anaemic children while Kupwara stands second with 62,491 number anaemic children. Budgam stands third with 54,203 numbers of anaemic children. In Srinagar, the numbers of anaemic children are 51,730 and in Baramulla, number of anaemic children are 48, 307.
“In Jammu, the numbers of anaemic children are around 47,000. In Rajouri, the numbers of anaemic children are around 34,000 while in Udhampur, the number of anaemic children are around 25, 000. In Poonch, the numbers of anaemic children are around 19,000”, the data reveals.
As per the NITI Aayog study report, 18 out of 20 districts show public health concern regarding the number of stunted children in J&K.
“Anantnag district has the highest number of 27, 578 stunted children. In Srinagar, there are 24, 680 stunted children and in Kupwara, there are 21, 982 stunted children, with Jammu having 20, 178 and in Budgam there are 19, 025 stunted children,” reveals the data.
It further reveals that in Rajouri there are more around 15, 000 stunted children. In Baramulla, there are 18,000 stunted children. In Kathua, there are around 8,000 stunted children. In Poonch, there are around 10,000 stunted children. In Ramban, there are around 7,000 stunted children. In Udhampur, there are around 15, 000 stunted children. In Doda, there are around 11,000 stunted children. In Kishtwar, there are around 5,000 stunted children.
COVID19 vaccines effective enough, no need for third booster jab: Lancet
(Asian News Hub) – Vaccines are effective enough at preventing severe cases of Covid-19 that there is no current need for the general population to be given third doses, according to a report in The Lancet published Monday.
Some countries have started offering extra doses over fears about the much more contagious Delta variant, causing the World Health Organization to call for a moratorium on third jabs amid concerns about vaccine supplies to poorer nations, where millions have yet to receive their first jab.
The new report by scientists, including from the WHO, concluded that even with the threat of Delta, “booster doses for the general population are not appropriate at this stage in the pandemic”.
The authors, who reviewed observational studies and clinical trials, found that vaccines remain highly effective against severe symptoms of Covid-19, across all the main virus variants including Delta, although they had lower success in preventing asymptomatic cases of the disease.
“Taken as a whole, the currently available studies do not provide credible evidence of substantially declining protection against severe disease, which is the primary goal of vaccination,” said lead author Ana-Maria Henao-Restrepo, of the WHO.
She said vaccine doses should be prioritised to people around the world still waiting for a jab.
“If vaccines are deployed where they would do the most good, they could hasten the end of the pandemic by inhibiting further evolution of variants,” she added.
COVID-19: Samba becomes first district to complete vaccination for all above 18 years
Instead of waiting for people to come, we reached out to them: DC Samba; LG congratulates for achieving milestone
(Asian News Hub) – Amid the ongoing Covid vaccination drive in Jammu and Kashmir Union Territory, Samba has become the first district in giving the first dose of Covid vaccine to all above 18 years of age.
A top health official told news agency—Kashmir News Observer (KNO) that there are around 241,000 persons in the district in between 18-44 age group and all of them have already got their first dose of Covid vaccine.
He said that around 78,000 (33 percent) people have also got second dose of Covid vaccine and the process of vaccinating more and more people is going on. “It was possible only due to the efforts of health workers and front line workers who have worked tirelessly to achieve this milestone,” the official said.
District Magistrate Samba Anuradha Gupta said that since the beginning Samba district started the vaccination process strategically and Samba was among first few districts which completed vaccination process of all above 45 years of age.
“Instead of waiting for people to come to us, we went to them. We had constituted mobile teams to reach everyone. We were vaccinating above 45 age group the positivity and mortality rate started declining and people understood the importance of vaccination,” Gupta said.
She said that then people above 18 years came on their own without need of any mobilisation and “our efforts are on complete second dose process at an earliest.”
Meanwhile LG Manoj Sinha has congratulated the Covid management team of Samba and health care workers for their tireless efforts in completing 100 percent vaccination of above 18 years of age. He hoped that other districts will catch up soon and complete this process as well.
“Congratulations to Covid mgmt team of Samba & health care workers for their tireless effort to ensure 100% vaccination of above 18 yrs of age.Samba becomes first distt. of J&K to achieve this milestone & I am sure other districts will catch up soon,” Office of LG tweeted.
Encounter starts in Chanapora, Sgr
Centre to send more forces to J&K
Won’t allow disruption of peace; damage to communal fabric of J&K at any cost: DGP Dilbagh Singh
- State6 days ago
Militant from Sgr involved in recent civilian killings killed in Pulwama gunfight: IGP
- State7 days ago
Army man killed in Poonch gunfight, traffic on highway stopped
- State7 days ago
Three days after killing of 5 soldiers; two soldiers killed in fresh gunbattle at Poonch’s Mendhar
- National6 days ago
AIIMS doctor booked for raping colleague
- State6 days ago
In 3 hours; two LeT (TRF) militants killed in Pulwama, Sgr encounters: Police
- State6 days ago
Militant killed in Bemina Sgr
- State7 days ago
J&K will soon be affordable destination in country: Sarmad Hafeez
- State6 days ago
Will live and die with Muslims; no question of migration: non-migrant KPs